Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Revenga-Martínez, Marcelino
55  Ergebnisse:
Personensuche X
?
1

Subclinical synovitis impact on the progression of lupus jo..:

Guillén-Astete, Carlos A ; Revenga-Martínez, Marcelino ; Zea-Mendoza, Antonio C...
Lupus.  33 (2024)  6 - p. 638-643 , 2024
Link: https://doi.org/10.1177/..
 
?
2

Prevalence of subclinical synovitis of the hand in patients..:

Guillén-Astete, Carlos A ; Revenga-Martinez, Marcelino ; Zea-Mendoza, Antonio.
Lupus.  29 (2020)  11 - p. 1423-1429 , 2020
Link: https://doi.org/10.1177/..
 
?
3

Epidemiology and clinical characteristics of psoriatic arth..:

Aguado Casanova, Víctor ; Ventas, Beatriz ; Arroyo Palomo, Jaime...
International Ophthalmology.  43 (2022)  3 - p. 771-777 , 2022
Link: https://doi.org/10.1007/..
 
?
4

Cystic Lesion of the Calcaneus. Intraosseous Lipoma:

Revenga Martínez, Marcelino ; Bachiller Corral, Francisco Javier ; Rubio García, Javier..
Reumatología Clínica (English Edition).  3 (2007)  3 - p. 139-142 , 2007
Link: https://doi.org/10.1016/..
 
?
5

Eficacia, evaluación económica y satisfacción del paciente ..:

Revenga Martínez, Marcelino
http://hdl.handle.net/10486/1929.  , 2014
Link: http://hdl.handle.net/10..
 
?
6

VIP/VPAC Axis Expression in Immune-Mediated Inflammatory Di..:

Lamana, Amalia ; Castro-Vázquez, David ; de la Fuente, Hortensia...
International Journal of Molecular Sciences.  23 (2022)  15 - p. 8578 , 2022
Link: https://doi.org/10.3390/..
 
?
7

Anti-IL-6 Receptor Tocilizumab in Refractory Graves' Orbito..:

Sánchez-Bilbao, Lara ; Martínez-López, David ; Revenga, Marcelino...
Journal of Clinical Medicine.  9 (2020)  9 - p. 2816 , 2020
Link: https://doi.org/10.3390/..
 
?
8

Comparative Study of Infliximab Versus Adalimumab in Refrac..:

Atienza-Mateo, Belén ; Martín-Varillas, José Luis ; Calvo-Río, Vanesa...
http://hdl.handle.net/10668/14169.  , 2019
Link: http://hdl.handle.net/10..
 
?
9

Efficacy of Tocilizumab in Patients With Moderate-to-Severe..:

Perez-Moreiras, Jose V. ; Gomez-Reino, Juan J. ; Maneiro, Jose R....
American Journal of Ophthalmology.  195 (2018)  - p. 181-190 , 2018
Link: https://doi.org/10.1016/..
 
?
10

VIP/VPAC Axis Expression in Immune-Mediated Inflammatory Di..:

Amalia Lamana ; David Castro-Vázquez ; Hortensia de la Fuente...
Molecular Genetics and Genomics.  , 2022
Link: https://doi.org/10.3390/..
 
?
11

VIP/VPAC Axis Expression in Immune-Mediated Inflammatory Di..:

Amalia Lamana ; David Castro-Vázquez ; Hortensia de la Fuente...
https://www.mdpi.com/1422-0067/23/15/8578.  , 2022
Link: https://doi.org/10.3390/..
 
?
12

Anti-IL-6 Receptor Tocilizumab in Refractory Graves? Orbito..:

Lara Sánchez-Bilbao ; David Martínez-López ; Marcelino Revenga...
https://doi.org/10.3390/jcm9092816.  , 2020
Link: http://hdl.handle.net/10..
 
?
13

Anti-IL-6 Receptor Tocilizumab in Refractory Graves' Orbito..:

Lara Sánchez-Bilbao ; David Martínez-López ; Marcelino Revenga...
https://www.mdpi.com/2077-0383/9/9/2816.  , 2020
Link: https://doi.org/10.3390/..
 
?
14

Anti-IL-6 Receptor Tocilizumab in Refractory Graves' Orbito..:

Lara Sánchez-Bilbao ; David Martínez-López ; Marcelino Revenga...
Ophthalmology.  , 2020
Link: https://doi.org/10.3390/..
 
?
15

VIP/VPAC Axis Expression in Immune-Mediated Inflammatory Di..:

Lamana, Amalia ; Castro-Vázquez, David ; de la Fuente, Hortensia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369218/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15